美股
Lead report
Exicure Receives Nasdaq Deficiency Notice for Shareholders' Equity, Faces Delisting Risk
Biotech firm Exicure gets a Nasdaq warning for shareholders' equity falling below $2.5 million, with 45 days to submit a compliance plan. Understand the company's background, market reaction, and potential implications.
